Premium Reports
Contact KLAS
 Download Report    Zoom in charts

Preferences

Add Bookmark   Bookmark

Related Series

 No Related Series

 End chart zoom
Points of Light 2025 Case Study 1 Points of Light 2025 Case Study 1
* A page refresh may be necessary to see the updated image
New

Points of Light 2025 Case Study 1
Leveraging Innovative Technology to Streamline Medication Prior Authorizations

author - Boyd Stewart
Author
Boyd Stewart
author - Aurene Wilford
Author
Aurene Wilford
 
May 13, 2025 | Read Time: 1  minute

For certain medications, obtaining prior authorization is a necessary step to ensuring effective, safe treatment for patients. The collaborators in this study recognized that the process for obtaining this authorization was not very efficient, adding manual, time-consuming tasks to physicians’ and staff’s already heavy workload. To improve efficiency, the collaborators created innovative capabilities that helped automate the submission and approval process for select drugs, including diabetic-related GLP-1 drugs. The technology has reduced approval times, denial rates, and physician abandonment rates, resulting in quicker access for patients to needed medication.

to see the full dataset.

If you don't have a login, getting started is easy.

Provider Organizations
Fill out our registration form to verify your organization.
HIT Companies
Contact a KLAS representative for plans and pricing.

Key Findings:

  1. Executive Summary
    • The Collaborators
  2. Points of Friction—Challenges to Be Solved
  3. Action Plan—How the Collaborators Worked Together to Reduce Friction
  4. Points of Light—Outcomes Achieved Through Collaboration
  5. Lessons Learned—What Best Practices Can Other Organizations Replicate?
  6. What's Next?—Vision for the Future
author - Natalie Hopkins
Writer
Natalie Hopkins
author - Jess Wallace-Simpson
Designer
Jess Wallace-Simpson
author - Joel Sanchez
Project Manager
Joel Sanchez
 Download Report

This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2025 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.